2026-03-02 Drugs SFDA Grants Orphan Drug Designation to "HYRNUO" for Advanced Non-Small Cell Lung Cancer
2026-01-16 Drugs SFDA Approves Registration of “Anktiva” for the Treatment of Bladder and Lung Cancer
2025-12-01 Drugs Global Leadership for Increasing Patient Accessibility, SFDA Expands Lojuxta Indication to Include Treatment of Children with Homozygous Familial Hypercholesterolemia (HoFH)
2025-10-09 Drugs SFDA Approves the Registration of Qalsody for the Treatment of Amyotrophic Lateral Sclerosis (ALS)
2025-09-01 Medical Devices SFDA Approves Innovative Biotechnology-Based Diagnostic Test for the Early Detection of Alzheimer's Disease
